Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Roya Feyznezhad"'
Autor:
Chitra Upadhyay, Priyanka Rao, Mohammad Amin Behzadi, Roya Feyznezhad, Gregory S. Lambert, Rajnish Kumar, Madhu Kumar, Weiming Yang, Xunqing Jiang, Christina C. Luo, Arthur Nadas, James Arthos, Xiang-Peng Kong, Hui Zhang, Catarina E. Hioe, J. Andrew Duty
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionHIV-1 envelope (Env) is the key target for antibodies (Abs) against the virus and thus an important HIV-1 vaccine component. Env is synthesized from a gp160 precursor with a signal peptide (SP) at its N-terminus. This study investigated t
Externí odkaz:
https://doaj.org/article/0dc36d13c96d45f2af750673eba6e9f0
Autor:
Catarina E Hioe, Guangming Li, Xiaomei Liu, Ourania Tsahouridis, Xiuting He, Masaya Funaki, Jéromine Klingler, Alex F Tang, Roya Feyznezhad, Daniel W Heindel, Xiao-Hong Wang, David A Spencer, Guangnan Hu, Namita Satija, Jérémie Prévost, Andrés Finzi, Ann J Hessell, Shixia Wang, Shan Lu, Benjamin K Chen, Susan Zolla-Pazner, Chitra Upadhyay, Raymond Alvarez, Lishan Su
Publikováno v:
PLoS Pathogens, Vol 18, Iss 1, p e1010183 (2022)
Antibodies are principal immune components elicited by vaccines to induce protection from microbial pathogens. In the Thai RV144 HIV-1 vaccine trial, vaccine efficacy was 31% and the sole primary correlate of reduced risk was shown to be vigorous ant
Externí odkaz:
https://doaj.org/article/fd5aefa035fe437aa866a6e470cde8fa
Autor:
Mohammad Amin Behzadi, Victor Hugo Leyva-Grado, Mandana Namayandeh, Atoosa Ziyaeyan, Roya Feyznezhad, Hedayat Dorzaban, Marzieh Jamalidoust, Mazyar Ziyaeyan
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Viral hepatitis is a global public health problem affecting millions of people worldwide, causing thousands of deaths due to acute and persistent infection, cirrhosis, and liver cancer. Providing updated serologic data can improve
Externí odkaz:
https://doaj.org/article/2bcb1c535afd481e9e842136dd3faa2f
Autor:
Chitra Upadhyay, Roya Feyznezhad, Liwei Cao, Kun-Wei Chan, Kevin Liu, Weiming Yang, Hui Zhang, Jason Yolitz, James Arthos, Arthur Nadas, Xiang-Peng Kong, Susan Zolla-Pazner, Catarina E Hioe
Publikováno v:
PLoS Pathogens, Vol 16, Iss 12, p e1009185 (2020)
HIV-1 envelope (Env) is a trimer of gp120-gp41 heterodimers, synthesized from a precursor gp160 that contains an ER-targeting signal peptide (SP) at its amino-terminus. Each trimer is swathed by ~90 N-linked glycans, comprising complex-type and oligo
Externí odkaz:
https://doaj.org/article/3bec827836d246bca6d4ddb8237d9715
Publikováno v:
Viruses, Vol 14, Iss 4, p 808 (2022)
HIV-1 Env signal peptide (SP) is an important contributor to Env functions. Env is generated from Vpu/Env encoded bicistronic mRNA such that the 5′ end of Env-N-terminus, that encodes for Env-SP overlaps with 3′ end of Vpu. Env SP displays high s
Externí odkaz:
https://doaj.org/article/34d2ffe7330b4d50b9bf45289d0508e3
Autor:
Chitra Upadhyay, Roya Feyznezhad, Weiming Yang, Hui Zhang, Susan Zolla-Pazner, Catarina E Hioe
Publikováno v:
PLoS Pathogens, Vol 14, Iss 1, p e1006812 (2018)
HIV-1 envelope glycoprotein (Env) mediates virus attachment and entry into the host cells. Like other membrane-bound and secreted proteins, HIV-1 Env contains at its N terminus a signal peptide (SP) that directs the nascent Env to the endoplasmic ret
Externí odkaz:
https://doaj.org/article/7d154d060d0749c2a33a0496e3d4d967
Autor:
Catarina E. Hioe, Guangming Li, Xiaomei Liu, Ourania Tsahouridis, Xiuting He, Masaya Funaki, Jéromine Klingler, Alex F. Tang, Roya Feyznezhad, Daniel W. Heindel, Xiao-Hong Wang, David A. Spencer, Guangnan Hu, Namita Satija, Jérémie Prévost, Andrés Finzi, Ann J. Hessell, Shixia Wang, Shan Lu, Benjamin K. Chen, Susan Zolla-Pazner, Chitra Upadhyay, Raymond Alvarez, Lishan Su
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 18, Iss 1, p e1010183 (2022)
PLoS Pathogens, Vol 18, Iss 1, p e1010183 (2022)
Antibodies are principal immune components elicited by vaccines to induce protection from microbial pathogens. In the Thai RV144 HIV-1 vaccine trial, vaccine efficacy was 31% and the sole primary correlate of reduced risk was shown to be vigorous ant
Autor:
Liwei Cao, Jason Yolitz, Catarina E. Hioe, James Arthos, Chitra Upadhyay, Roya Feyznezhad, Hui Zhang, Kevin Liu, Arthur Nádas, Xiang-Peng Kong, Kun-Wei Chan, Susan Zolla-Pazner, Weiming Yang
HIV-1 envelope (Env) is a trimer of gp120-gp41 heterodimers, synthesized from a precursor gp160 that contains an ER-targeting signal peptide (SP) at its amino-terminus. Each trimer is swathed by ∼90 N-linked glycans, comprising complex-type and oli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::555210a5b1af7688de6d438a47fe90d5
https://doi.org/10.1101/2020.07.21.212183
https://doi.org/10.1101/2020.07.21.212183
Autor:
James Arthos, Arthur Nádas, Xiang-Peng Kong, Hui Zhang, Susan Zolla-Pazner, Chitra Upadhyay, Weiming Yang, Kevin Liu, Liwei Cao, Roya Feyznezhad, Kun Wei Chan, Jason Yolitz, Catarina E. Hioe
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 16, Iss 12, p e1009185 (2020)
PLoS Pathogens, Vol 16, Iss 12, p e1009185 (2020)
HIV-1 envelope (Env) is a trimer of gp120-gp41 heterodimers, synthesized from a precursor gp160 that contains an ER-targeting signal peptide (SP) at its amino-terminus. Each trimer is swathed by ~90 N-linked glycans, comprising complex-type and oligo
Autor:
Chitra Upadhyay, Catarina E. Hioe, Roya Feyznezhad, Weiming Yang, Hui Zhang, Susan Zolla-Pazner
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 14, Iss 1, p e1006812 (2018)
PLoS Pathogens, Vol 14, Iss 1, p e1006812 (2018)
HIV-1 envelope glycoprotein (Env) mediates virus attachment and entry into the host cells. Like other membrane-bound and secreted proteins, HIV-1 Env contains at its N terminus a signal peptide (SP) that directs the nascent Env to the endoplasmic ret